Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Vasan

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Science (New York, N.Y.)|November 9, 2019
Double <i>PIK3CA</i> mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitorsNeil Vasan, Pedram Razavi, Jared L Johnson, et al.
Cancer Discovery|October 2, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase InhibitorsEmiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, et al.
Cancer Cell|June 16, 2023
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunityPatricia Ho, Johannes C Melms, Meri Rogava, et al.
Nature Cancer|September 1, 2020
Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.
Nature|May 8, 2024
The intrinsic substrate specificity of the human tyrosine kinomeTomer M Yaron-Barir, Brian A Joughin, Emily M Huntsman, et al.
Cancer Discovery|December 29, 2020
Metastasis and Immune Evasion from Extracellular cGAMP HydrolysisJun Li, Mercedes A Duran, Ninjit Dhanota, et al.
Nature|January 11, 2023
An atlas of substrate specificities for the human serine/threonine kinomeJared L Johnson, Tomer M Yaron, Emily M Huntsman, et al.
Cancer Cell|September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersPedram Razavi, Matthew T Chang, Guotai Xu, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Science (New York, N.Y.)|November 9, 2019
Double <i>PIK3CA</i> mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitorsNeil Vasan, Pedram Razavi, Jared L Johnson, et al.
Cancer Discovery|October 2, 2020
TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase InhibitorsEmiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, et al.
Cancer Cell|June 16, 2023
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunityPatricia Ho, Johannes C Melms, Meri Rogava, et al.
Nature Cancer|September 1, 2020
Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.
Nature|May 8, 2024
The intrinsic substrate specificity of the human tyrosine kinomeTomer M Yaron-Barir, Brian A Joughin, Emily M Huntsman, et al.
Cancer Discovery|December 29, 2020
Metastasis and Immune Evasion from Extracellular cGAMP HydrolysisJun Li, Mercedes A Duran, Ninjit Dhanota, et al.
Nature|January 11, 2023
An atlas of substrate specificities for the human serine/threonine kinomeJared L Johnson, Tomer M Yaron, Emily M Huntsman, et al.
Cancer Cell|September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersPedram Razavi, Matthew T Chang, Guotai Xu, et al.
Pageof 4